Arcellx Stock Performance
| ACLX Stock | USD 89.41 1.03 1.14% |
On a scale of 0 to 100, Arcellx holds a performance score of 11. The firm shows a Beta (market volatility) of 2.34, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Arcellx will likely underperform. Please check Arcellx's coefficient of variation, semi variance, period momentum indicator, as well as the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Arcellx's price patterns will revert.
Risk-Adjusted Performance
11 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Arcellx are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting essential indicators, Arcellx showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 1.64 | Five Day Return 5.82 | Year To Date Return 63.72 | Ten Year Return 447.19 | All Time Return 447.19 |
1 | Acquisition by Behbahani Ali of 8011 shares of Arcellx at 51.3 subject to Rule 16b-3 | 09/06/2024 |
2 | Disposition of 1500 shares by Patel Kavita of Arcellx at 74.41 subject to Rule 16b-3 | 09/10/2024 |
3 | Disposition of 8726 shares by Michelle Gilson of Arcellx at 77.8809 subject to Rule 16b-3 | 09/17/2024 |
4 | Arcellx, Inc. Position Lessened by Perceptive Advisors LLC - MarketBeat | 09/30/2024 |
5 | Disposition of 1500 shares by Patel Kavita of Arcellx at 82.24 subject to Rule 16b-3 | 10/01/2024 |
6 | Disposition of 1500 shares by Patel Kavita of Arcellx at 89.69 subject to Rule 16b-3 | 10/22/2024 |
7 | A Look At The Fair Value Of Arcellx, Inc. | 10/28/2024 |
8 | Arcellx Releases Clinical Data from Phase 1 and iMMagine-1 Studies for Multiple Myeloma Patients On November 5, 2024, Arcellx, Inc. made public an abstract cont... | 11/05/2024 |
9 | Lululemon To Rally Around 19 Here Are 10 Top Analyst Forecasts For Wednesday | 11/06/2024 |
10 | Disposition of 8478 shares by Patel Kavita of Arcellx at 99.2995 subject to Rule 16b-3 | 11/07/2024 |
11 | Disposition of 25787 shares by Patel Kavita of Arcellx at 105.4607 subject to Rule 16b-3 | 11/08/2024 |
12 | Disposition of 3005 shares by Patel Kavita of Arcellx at 106.9083 subject to Rule 16b-3 | 11/11/2024 |
13 | arcellx CFO Michelle Gilson sells 1.24 million in stock | 11/13/2024 |
14 | Disposition of 100 shares by Michelle Gilson of Arcellx at 95.0 subject to Rule 16b-3 | 11/15/2024 |
15 | Acquisition by Michelle Gilson of 3000 shares of Arcellx at 8.66 subject to Rule 16b-3 | 11/19/2024 |
| Begin Period Cash Flow | 66.7 M |
Arcellx |
Arcellx Relative Risk vs. Return Landscape
If you would invest 6,930 in Arcellx on August 28, 2024 and sell it today you would earn a total of 2,011 from holding Arcellx or generate 29.02% return on investment over 90 days. Arcellx is currently generating 0.4566% in daily expected returns and assumes 3.2282% risk (volatility on return distribution) over the 90 days horizon. In different words, 28% of stocks are less volatile than Arcellx, and 91% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Arcellx Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Arcellx's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Arcellx, and traders can use it to determine the average amount a Arcellx's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1414
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ACLX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.23 actual daily | 28 72% of assets are more volatile |
Expected Return
| 0.46 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
| 0.14 actual daily | 11 89% of assets perform better |
Based on monthly moving average Arcellx is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Arcellx by adding it to a well-diversified portfolio.
Arcellx Fundamentals Growth
Arcellx Stock prices reflect investors' perceptions of the future prospects and financial health of Arcellx, and Arcellx fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Arcellx Stock performance.
| Return On Equity | -0.11 | ||||
| Return On Asset | -0.0629 | ||||
| Profit Margin | (0.26) % | ||||
| Operating Margin | (1.29) % | ||||
| Current Valuation | 4.38 B | ||||
| Shares Outstanding | 54.07 M | ||||
| Price To Book | 10.12 X | ||||
| Price To Sales | 31.39 X | ||||
| Revenue | 110.32 M | ||||
| EBITDA | (64.14 M) | ||||
| Net Income | (70.69 M) | ||||
| Cash And Equivalents | 306.99 M | ||||
| Cash Per Share | 7.01 X | ||||
| Total Debt | 97.62 M | ||||
| Debt To Equity | 0.09 % | ||||
| Current Ratio | 10.16 X | ||||
| Book Value Per Share | 8.95 X | ||||
| Cash Flow From Operations | 207.57 M | ||||
| Earnings Per Share | (0.71) X | ||||
| Market Capitalization | 4.89 B | ||||
| Total Asset | 825.13 M | ||||
| Retained Earnings | (389.48 M) | ||||
| Working Capital | 598.12 M | ||||
About Arcellx Performance
Evaluating Arcellx's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Arcellx has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Arcellx has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.09) | (0.09) | |
| Return On Capital Employed | (0.13) | (0.13) | |
| Return On Assets | (0.09) | (0.09) | |
| Return On Equity | (0.15) | (0.14) |
Things to note about Arcellx performance evaluation
Checking the ongoing alerts about Arcellx for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Arcellx help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Arcellx had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 110.32 M. Net Loss for the year was (70.69 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Over 93.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from MacroaxisInsider: Acquisition by Michelle Gilson of 3000 shares of Arcellx at 8.66 subject to Rule 16b-3 |
- Analyzing Arcellx's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Arcellx's stock is overvalued or undervalued compared to its peers.
- Examining Arcellx's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Arcellx's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Arcellx's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Arcellx's stock. These opinions can provide insight into Arcellx's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Arcellx Stock Analysis
When running Arcellx's price analysis, check to measure Arcellx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcellx is operating at the current time. Most of Arcellx's value examination focuses on studying past and present price action to predict the probability of Arcellx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcellx's price. Additionally, you may evaluate how the addition of Arcellx to your portfolios can decrease your overall portfolio volatility.